Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$333M |
| 2 |
Alibaba
BABA
|
+$303M |
| 3 |
Pfizer
PFE
|
+$269M |
| 4 |
Microsoft
MSFT
|
+$264M |
| 5 |
Eversource Energy
ES
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Growth ETF
VUG
|
+$780M |
| 2 |
Linde
LIN
|
+$623M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$515M |
| 4 |
S&P Global
SPGI
|
+$449M |
| 5 |
UnitedHealth
UNH
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.66% |
| 2 | Healthcare | 13.63% |
| 3 | Financials | 11.69% |
| 4 | Communication Services | 9.98% |
| 5 | Consumer Discretionary | 9.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYKE
2551
DELISTED
SYKES Enterprises Inc
SYKE
| $531K | ﹤0.01% |
14,436
-10,917
| -43% | -$369K |
|
|
FG
2552
DELISTED
FGL Holdings Ordinary Shares
FG
| $531K | ﹤0.01% |
49,980
-46,328
| -48% | -$421K |
|
2553
Helix Energy Solutions
HLX
$1.4B
| $530K | ﹤0.01% |
55,300
-68,363
| -55% | -$592K |
|
2554
Westlake Chemical Partners
WLKP
$763M
| $524K | ﹤0.01% |
19,865
+11,953
| +151% | +$274K |
|
|
ZEPP
2555
Zepp Health
ZEPP
$66.4M
| $524K | ﹤0.01% |
10,915
+1,706
| +19% | +$71.5K |
|
|
CCH.WS
2556
CALL
DELISTED
Collier Creek Holdings Warrants, each whole warrant exercisable for one Class A ordinary share at an
CCH.WS
| $523K | ﹤0.01% |
388,138
+295,283
| +318% | +$401K |
|
2557
AMC Entertainment Holdings
AMC
$2.52B
| $522K | ﹤0.01% |
7,225
-366
| -5% | -$32.2K |
|
2558
CEVA Inc
CEVA
$910M
| $521K | ﹤0.01% |
19,372
+8,296
| +75% | +$227K |
|
2559
Immatics
IMTX
$1.18B
| $519K | ﹤0.01% |
+50,000
| New | +$515K |
|
|
AKS
2560
DELISTED
AK Steel Holding Corp
AKS
| $519K | ﹤0.01% |
158,191
-21,170
| -12% | -$58.7K |
|
|
ODP
2561
DELISTED
ODP
ODP
| $518K | ﹤0.01% |
18,926
-3,519
| -16% | -$78.3K |
|
2562
Kornit Digital
KRNT
$705M
| $515K | ﹤0.01% |
15,071
+11,452
| +316% | +$380K |
|
2563
TORM
TRMD
$3.1B
| $515K | ﹤0.01% |
47,593
+21,288
| +81% | +$202K |
|
|
OSG
2564
Octave Specialty Group
OSG
$243M
| $514K | ﹤0.01% |
23,893
-15,917
| -40% | -$326K |
|
2565
KRONOS Worldwide
KRO
$693M
| $514K | ﹤0.01% |
38,450
-10,087
| -21% | -$132K |
|
2566
Old Second Bancorp
OSBC
$1.29B
| $514K | ﹤0.01% |
38,227
+98
| +0.3% | +$1.22K |
|
|
GRTS
2567
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $513K | ﹤0.01% |
57,357
+10,609
| +23% | +$88.4K |
|
|
AVX
2568
DELISTED
AVX Corporation
AVX
| $512K | ﹤0.01% |
25,071
-7,891
| -24% | -$136K |
|
2569
Marcus & Millichap
MMI
$1.16B
| $510K | ﹤0.01% |
13,730
+1,645
| +14% | +$59.1K |
|
2570
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
| $509K | ﹤0.01% |
12,060
-150
| -1% | -$5.72K |
|
2571
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
| $508K | ﹤0.01% |
5,101
+479
| +10% | +$47.5K |
|
2572
Middlesex Water
MSEX
$1.08B
| $507K | ﹤0.01% |
8,008
-10,744
| -57% | -$681K |
|
2573
Clear Channel Outdoor Holdings
CCO
$1.23B
| $505K | ﹤0.01% |
177,154
+142,239
| +407% | +$360K |
|
2574
Akebia Therapeutics
AKBA
$354M
| $504K | ﹤0.01% |
79,952
+33,721
| +73% | +$160K |
|
|
CHX
2575
DELISTED
ChampionX
CHX
| $501K | ﹤0.01% |
14,961
-22,765
| -60% | -$620K |
|
Similar funds
Deutsche Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Deutsche Bank held 5,318 positions worth $153B, up 6.6% from $144B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Deutsche Bank withdrew a net $5.3B in Q4 2019, closing 262 positions and reducing 1,924 holdings. Its most notable exit was Celgene Corp, an estimated $273M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Deutsche Bank opened a new position in XP worth $32.9M.
- Deutsche Bank's largest Q4 2019 buy was XP: 853,950 shares worth $32.9M.
- Deutsche Bank added most to Johnson & Johnson in Q4 2019, an estimated $333M increase.
- Deutsche Bank's biggest Q4 2019 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $780M.
- Deutsche Bank fully exited Celgene Corp in Q4 2019, selling an estimated $273M.
- Deutsche Bank's ten largest holdings make up 17% of its $153B portfolio in Q4 2019.
- Deutsche Bank opened 407 new positions and closed 262 in Q4 2019.
- Deutsche Bank's portfolio value rose 6.6% quarter-over-quarter to $153B.
Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.